Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 11 Show results per page	View Search Criteria \| Help With Results


1.		Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Completed				18 and over				Pharmaceutical / Industry				A1501038 NCT00143312

Last Modified: 5/14/2007 First Published: 7/1/1997


2.		Phase III Randomized Study of Voriconazole vs Amphotericin B in Immunocompromised Patients With Acute Invasive Aspergillosis (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				12 and over				Pharmaceutical / Industry				EORTC-19961 PFIZER-150-307-000, NCT00003031

Last Modified: 9/1/1999 First Published: 5/1/1998


3.		Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				12 and over				NCI, Pharmaceutical / Industry				NCI-98-C-0063 PFIZER-150-603

Last Modified: 1/1/2001 First Published: 7/1/1999


4.		Phase III Study of Voriconazole in Patients With Invasive Fungal Infections (Summary Last Modified 01/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				12 and over				NCI				NCI-99-C-0094B NCI-99-C-0094


5.		Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				2 to 12				NCI, NHLBI				416 BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803

Last Modified: 12/19/2004 First Published: 4/23/2003


6.		Phase II Randomized Pilot Study of Voriconazole With or Without Interferon gamma in Patients With Invasive Aspergillosis or Other Filamentous Fungal Infections

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				2 and over				NCI				NCI-03-C-0111 NCT00059878

Last Modified: 4/1/2005 First Published: 7/26/2003


7.		Phase II Pilot Study of Voriconazole for the Prevention of Systemic Fungal Infection in Pediatric Patients With Neutropenia After Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				2 to 11				NCI				NCI-03-C-0218 NCT00066599

Last Modified: 10/1/1998 First Published: 11/1/1997


8.		Phase I Study of Voriconazole versus Fluconazole in Patients with Hematologic Malignancies, Hematologic Conditions, or Solid Tumors at Risk for Aspergillosis (Summary Last Modified 10/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Closed				18 and over				Pharmaceutical / Industry				MCV-CCHR-9603-2H PFIZER-95CK39-0673, NCI-G97-1325

Last Modified: 3/1/2001 First Published: 8/1/2000


9.		Phase I Study of Voriconazole in Children Who Require Treatment for the Prevention of Systemic Fungal Infection (Summary Last Modified 03/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Completed				2 to 12				NCI				NCI-00-C-0150

Last Modified: 7/12/2007 First Published: 2/20/2004


10.		Randomized Study of Voriconazole Versus Itraconazole for the Prevention of Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				12 and over				NCI				UCLA-0307071 NCT00079222

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute